FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

417715003: Genitourinary agent (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2547585019 Genitourinary agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2549937017 Genitourinary agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2547585019 Genitourinary agent (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2547585019 Genitourinary agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2549937017 Genitourinary agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2549937017 Genitourinary agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    216201000077116 agent pour l'appareil génito-urinaire fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
    216201000077116 agent pour l'appareil génito-urinaire fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    agent pour l'appareil génito-urinaire Is a agent pour l'appareil génital false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Cellulose sodium phosphate (substance) Is a False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Genitourinary drug (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Potassium bicarbonate+citric acid 1.39g/1.14g soluble tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Potassium citrate 3g/sachet granules The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Sodium citrate mixture BPC The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely sodium citrate 4 gram/1 sachet granules for conventional release oral solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Ammonium chloride mixture (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Sodium citrate 3% irrigation solution (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Miscellaneous cystitis remedies The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Phenazopyridine hydrochloride (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Medicinal product acting as urinary acidifier (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing phenazopyridine hydrochloride and sulfamethoxazole and trimethoprim The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Drugs for urinary retention The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Drugs for enuresis, urinary frequency and incontinence The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Hyoscyamine- and phenazopyridine- and secbutabarbital-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Bulking preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing sodium citrate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Phenazopyridine- and sulfafurazole-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Phenazopyridine- and sulfamethoxazole-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Azo-Sulfamethoxazole The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Sodium citrate 4.4g/sachet powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing phenazopyridine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Phenazopyridine hydrochloride 95 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Phenazopyridine hydrochloride 150 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Phenazopyridine hydrochloride 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Phenazopyridine hydrochloride 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Phenazopyridine hydrochloride 97.2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing oxytetracycline hydrochloride and phenazopyridine hydrochloride and sulfamethizole The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing ammonium chloride (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing ammonium chloride and diphenhydramine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Hydroxyapatite 3.32 g oral granules sachet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing durapatite (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Ammonium chloride- and caffeine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing sodium bicarbonate and sodium citrate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing calcium hydroxyapatite and carboxymethylcellulose sodium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing carboxymethylcellulose sodium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent pour l'appareil génito-urinaire Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    SAME AS association reference set (foundation metadata concept)

    Back to Start